E-LIB Suche - Ergebnisse für: Janser, Philipp

1

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 I..:

Velcicky, Juraj ; Janser, Philipp ; Gommermann, Nina...
Journal of Medicinal Chemistry. 67 (2024) 2 - p. 1544-1562 , 2024

Link: https://doi.org/10.1021/..

2

Discovery and Optimization of Novel SUCNR1 Inhibitors: Desi..:

Velcicky, Juraj ; Wilcken, Rainer ; Cotesta, Simona...
Journal of Medicinal Chemistry. 63 (2020) 17 - p. 9856-9875 , 2020

Link: https://doi.org/10.1021/..

3

Discovery of LOU064 (Remibrutinib), a Potent and Highly Sel..:

Angst, Daniela ; Gessier, François ; Janser, Philipp...
Journal of Medicinal Chemistry. 63 (2020) 10 - p. 5102-5118 , 2020

Link: https://doi.org/10.1021/..

4

Design of Potent and Selective Covalent Inhibitors of Bruto..:

Pulz, Robert ; Angst, Daniela ; Dawson, Janet...
ACS Medicinal Chemistry Letters. 10 (2019) 10 - p. 1467-1472 , 2019

Link: https://doi.org/10.1021/..

5

Pathophysiological Consequences of a Break in S1P1-Dependen..:

Bigaud, Marc ; Dincer, Zuhal ; Bollbuck, Birgit...
PLOS ONE. 11 (2016) 12 - p. e0168252 , 2016

Link: https://doi.org/10.1371/..

6

A Potent and Selective S1P1 Antagonist with Efficacy in Exp..:

Quancard, Jean ; Bollbuck, Birgit ; Janser, Philipp...
Chemistry & Biology. 19 (2012) 9 - p. 1142-1151 , 2012

Link: https://doi.org/10.1016/..

7

An Oral Sphingosine 1-Phosphate Receptor 1 (S1P1) Antagonis..:

Angst, Daniela ; Janser, Philipp ; Quancard, Jean...
Journal of Medicinal Chemistry. 55 (2012) 22 - p. 9722-9734 , 2012

Link: https://doi.org/10.1021/..

8

A cassette-dosing approach for improvement of oral bioavail..:

Janser, Philipp ; Neumann, Ulf ; Miltz, Wolfgang..
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 10 - p. 2632-2636 , 2006

Link: https://doi.org/10.1016/..

9

Design and preparation of 2-benzamido-pyrimidines as inhibi..:

Waelchli, Rudolf ; Bollbuck, Birgit ; Bruns, Christian...
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 1 - p. 108-112 , 2006

Link: https://doi.org/10.1016/..

10

Highly diastereoselective Lewis acid promoted Claisen–Irela..:

Koch, Guido ; Janser, Philipp ; Kottirsch, Georg.
Tetrahedron Letters. 43 (2002) 27 - p. 4837-4840 , 2002

Link: https://doi.org/10.1016/..

11

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 I..:

Juraj Velcicky ; Philipp Janser ; Nina Gommermann...
doi:10.1021/acs.jmedchem.3c02098.s002. , 2024

Link: https://doi.org/10.1021/..

12

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 I..:

Juraj Velcicky ; Philipp Janser ; Nina Gommermann...
doi:10.1021/acs.jmedchem.3c02098.s001. , 2024

Link: https://doi.org/10.1021/..

13

Pathophysiological Consequences of a Break in S1P1-Dependen..:

Marc Bigaud ; Zuhal Dincer ; Birgit Bollbuck...
http://europepmc.org/articles/PMC5179015?pdf=render. , 2016

Link: https://doi.org/10.1371/..

14

Covid-19-Pandemie und Klimawandel als Beschleuniger des Str..:

Grunau, Philipp ; Janser, Markus ; Laible, Marie-Christine...
Series: IAB-Stellungnahme. , 2020

Link: http://hdl.handle.net/10..